Journal article
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial
Abstract
BACKGROUND: Chronic heart failure (CHF) is an important cause of hospital admission and death. Poor adherence to medication is common in some chronic illnesses and might reduce the population effectiveness of proven treatments. Because little is known about adherence in patients with CHF and about the consequences of non-adherence, we assessed the association between adherence and clinical outcome in the CHARM (Candesartan in Heart failure: …
Authors
Granger BB; Swedberg K; Ekman I; Granger CB; Olofsson B; McMurray JJ; Yusuf S; Michelson EL; Pfeffer MA; investigators FTC
Journal
The Lancet, Vol. 366, No. 9502, pp. 2005–2011
Publisher
Elsevier
Publication Date
12 2005
DOI
10.1016/s0140-6736(05)67760-4
ISSN
0140-6736